Report of the APhA Stakeholder Conference on Improving Patient Access to Injectable Medications.

Objectives: The APhA Stakeholder Conference on Improving Patient Access to Injectable Medications was convened to foster national dialogue to advance the pharmacist's role in the provision of injectable medication administration services (MAS) and related patient care services, and to establish pharmacy as a site of care for these injections. Participants discussed the distinct opportunities to maximize pharmacist scope of services, expand patient access to care, improve medication adherence, and enhance outcomes for patients on injectable medication therapies for a range of conditions. These elements were framed in terms of the practice model, the business model, and the necessary training and resources to support these activities. Data sources: National thought leaders within pharmacy practice, pharmacist employers, national pharmacy associations, and pharmaceutical companies were invited to participate in the conference on December 15, 2016. Participants provided perspectives on a series of structured questions around administrative and patient care issues associated with the expansion of pharmacy-based MAS. Outcomes from the discussions were supplemented with related information from the literature. Summary: The APhA Stakeholder Conference on Improving Patient Access to Injectable Medications explored how the pharmacy profession could advance a broad-based, profession-wide practice model for MAS across a wide spectrum of therapeutic classes. There is a significant public health need to expand access to patients and make MAS a widely available, predictable, measurable, and scalable service provided by pharmacists. Conference participants discussed scope of practice, service delivery, and business model barriers. They also identified tools and resources that are necessary to overcome those barriers to advance opportunities and develop long-term, sustainable strategies to increase access to MAS from community-based pharmacist practitioners. Conclusion: Conference outcomes provided specific guidance around the need to develop practice support to address public health needs and effectively advance pharmacist provision of MAS and related patient care services. Key recommendations included the development of national practice guidance, standardized education and training, practice-level tools and resources, and enhanced technology solutions. [ABSTRACT FROM AUTHOR]